Boehringer Ingelheim’s podcast called Taking Cancer On is back with episode 2. Hosted by Sebastian Hermelin, co-founder of War On Cancer, this next episode digs into clinical trials, which are considered a hope to hold on to for many people who experience cancer.
Episode 2: Under the surface of clinical trials
Expert Guests: Dr Victoria Zazulina, Corporate Vice President and Global Head of Oncology Medicine at Boehringer Ingelheim and Ivy Elkins, lung cancer survivor/advocate and co-founder of the EGFR resisters patient group.
In this episode, we discuss what the benefits, barriers, risks and rewards are of taking part in a cancer trial. Do physicians and people who go through cancer see things in the same light?
Take a listen to episode 2 here.
About Taking Cancer On, the podcast
In an effort to simplify the science behind Boehringer Ingelheim’s ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
If you haven’t already, make sure to listen to episode 1 here, with Dr. Darryl McConnell, Senior Vice President and Research Site Head for Boehringer Ingelheim, Austria, who talks about a breakthrough in KRAS research and the very beginnings of cancer research.
Or, listen to the War On Cancer podcast season 1 here.